Senators raise concerns on Sinovac's efficacy, cost

enablePagination: false
maxItemsPerPage: 10
maxPaginationLinks: 10

The country will kickoff its vaccination program next month, a huge step forward in the Covid-19 fight.

But concerns are growing over the efficacy of the China-made Sinovac vaccine,

One of the brands to be used in the initial distribution.

Now at least one Senator wants the Health department to cancel the purchase of this vaccine.

Our chief correspondent and anchor Pia Hontiveros has this report.